Type 2 diabetes with history of diabetic retinopathy (semaglutide specifically)
The rats in TAC + semaglutide group were administrated with semaglutide (1 mg/kg) (NovoNordiskA/S, Denmark) once a week, subcutaneously 22
Focus on sterile technique and consistent depth (subcutaneous, not intramuscular) rather than site selection.
Effect of alpha-tocopherol and beta-carotene supplementation on macrovascular complications and total mortality from diabetes: results of the ATBC Study
Affected individuals report experiencing serious health complications including stomach paralysis requiring hospitalization, persistent vomiting lasting four weeks or more, severe bowel obstructions, blood clots, and permanent vision loss injuries they claim were not disclosed on the drugs labeling
11 A dose-dependent decrease in liver chemistries was observed from 3 months to 18 months